Insulin resistance and
type 2 diabetes mellitus are associated with impaired postprandial secretion of
glucagon-like peptide-1 (GLP-1), a potent insulinotropic
hormone. The direct effects of
insulin and
insulin resistance on the L cell are unknown. We therefore hypothesized that the L cell is responsive to
insulin and that
insulin resistance impairs
GLP-1 secretion. The effects of
insulin and
insulin resistance were examined in well-characterized L cell models: murine GLUTag, human NCI-H716, and fetal rat intestinal cells. MKR mice, a model of chronic
hyperinsulinemia, were used to assess the function of the L cell in vivo. In all cells,
insulin activated the
phosphatidylinositol 3 kinase-Akt and
MAPK kinase (
MEK)-ERK1/2 pathways and stimulated
GLP-1 secretion by up to 275 +/- 58%.
Insulin resistance was induced by 24 h pretreatment with 10(-7) m
insulin, causing a marked reduction in activation of Akt and ERK1/2. Furthermore, both
insulin-induced
GLP-1 release and secretion in response to
glucose-dependent insulinotropic peptide and phorbol-12-myristate-13-acetate were significantly attenuated. Whereas inhibition of
phosphatidylinositol 3 kinase with
LY294002 potentiated
insulin-induced
GLP-1 release, secretion was abrogated by inhibiting the
MEK-ERK1/2 pathway with
PD98059 or by overexpression of a
kinase-dead MEK1-ERK2 fusion
protein. Compared with controls, MKR mice were
insulin resistant and displayed significantly higher fasting plasma
insulin levels. Furthermore, they had significantly higher basal
GLP-1 levels but displayed impaired
GLP-1 secretion after an oral
glucose challenge. These findings indicate that the intestinal L cell is responsive to
insulin and that
insulin resistance in vitro and in vivo is associated with impaired
GLP-1 secretion.